Sign in
Taking peopleNo phase

Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations

Key facts

Who runs it
Shandong University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
50 people, planned
Started
30 Sept 2023
Expected to end
31 Dec 2026
Type of study
Observational
Treatments tested
  • Piperacillin Sodium and Tazobactam Sodium for Injection
Record updated
10 October 2023

Who can take part

Age
18 years and older
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Patients over 18 years old
  • Pregnant women whose baby are at high risk of developing early-onset sepsis after birth have indications to use preventive or therapeutic antibiotics, and the antibiotics used are PIP/TAZO;
  • Patients and their families are fully aware of the research content and sign the informed consent form

Who cannot take part

  • Receiving other systemic trial drugs
  • Intolerance or serious adverse reactions to antibiotic use
  • Patients who stopped using PIP/TAZO more than 24 hours before delivery
  • There are other factors that the researchers think are not suitable for inclusion

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this study is to describe the population pharmacokinetic characteristics of piperacillin/tazobactam after intravenous administration in pregnant women during pregnancy and delivery, and to evaluate pharmacodynamic effectiveness and safety of piperacillin/tazobactam in pregnant women whose baby are at high risk of developing early-onset sepsis after birth.

Treatments tested

  • Piperacillin Sodium and Tazobactam Sodium for Injection

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations With High Risk for EOS
Record updated
10 October 2023